Public Consultation – Draft 2021-22 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP
Page last updated: 15 April 2021
Consultation on the content of the draft Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme and designated vaccines on the National Immunisation Program is now open.
This CRIS sets out the fees that will apply for the 2021-22 financial year and provides information on how the Department of Health (the Department) implements cost recovery for:
- Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for medicines seeking to be listed on the Pharmaceutical Benefits Scheme (PBS); or vaccines to be listed on the National Immunisation Program (NIP).
- Applicant-driven PBS listing and list management activities.
The National Health (Pharmaceuticals and Vaccines – Cost Recovery) Regulations 2009 will be amended and the final CRIS will be published before the fee changes take effect on 1 July 2021.
Department of Health welcomes your feedback
Please provide your comments on the content of the draft 2021-22 CRIS via email to PBS Cost Recovery. Consultation closes COB Thursday 29 April 2021.